Bionano Genomics (BNGO) Return on Sales (2017 - 2026)

Bionano Genomics (BNGO) has 10 years of Return on Sales data on file, last reported at 0.01% in Q1 2026.

• For the quarter ending Q1 2026, Return on Sales fell 1.0% year-over-year to 0.01%; the trailing twelve-month figure through Mar 2026 stood at 0.0% (up 3.0% YoY), and the FY2025 full-year result was 0.0%, up 4.0% from the prior year.
• Return on Sales declined to 0.01% in Q1 2026, from 0.02% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.02% in Q4 2025 to a low of 0.12% in Q3 2023.
• A 5-year average of 0.04% and a median of 0.04% in 2023 frame the typical range for Return on Sales.
• Across the five-year window, Return on Sales slipped 8 bps in 2023 and climbed 6 bps in 2025, its largest moves.
• Tracing BNGO's Return on Sales over 5 years: stood at 0.05% in 2022, then advanced by 13 bps to 0.04% in 2023, then jumped by 39 bps to 0.03% in 2024, then surged by 193 bps to 0.02% in 2025, then slumped by 153 bps to 0.01% in 2026.
• Business Quant data shows BNGO's Return on Sales at 0.01% in Q1 2026, 0.02% in Q4 2025, and 0.01% in Q3 2025.